Sinopia Biosciences, a biotechnology company based in San Diego, California, has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Dental and Craniofacial Research. The funding will be used to further develop Sinopia's oral mucositis program, focusing on the discovery and optimization of novel therapeutics. https://lnkd.in/g5nF8KKt
